Jabre Capital Partners’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-18,000
Closed -$305K 81
2018
Q3
$305K Sell
18,000
-30,000
-63% -$508K 0.1% 110
2018
Q2
$682K Buy
+48,000
New +$682K 0.05% 90